ERBB2 and breast neoplasm: We observed that the rate of positive expression (+) of UCHL1 protein is significantly higher in triple negative breast tumors (34.5%, 10/29) than that in luminal A (4.3%, 2/47), luminal B (4.2%, 2/48) and HER2+ (0%, 0/45) breast tumors.